Announces amendments and finalization of the number of share acquisition rights granted to employees and subsidiary employees, exercise price, and related details. Post-amendment employee grants total 96,317 units, aggregate 113,597 units, with an exercise price of 122,800 yen per unit. Total value of shares for employee grants is 11,827,727,600 yen and for officer grants is 2,121,984,000 yen. Number of assignees revised to 1,487 employees and 3,275 subsidiary employees, totaling 4,841 people. Finalization date is set for 2026-10-05.<\/p>\n","protected":false},"comment_status":"open","ping_status":"closed","template":"","meta":{"Ticker":"","DATE":"","longName":"","company_name_ja":"","fullTimeEmployees":0,"address":"","phone":"","website":"","industry":"","sector":"","regularMarketPrice":0,"financialCurrency":"","marketCap":0,"fiftyTwoWeekLow":0,"fiftyTwoWeekHigh":0,"epsTrailingTwelveMonths":0,"epsForward":0,"bookValue":0,"totalRevenue":0,"OperatingIncome":0,"operatingMargins":0,"NetIncome":0,"profitMargins":0,"ebitda":0,"trailingPE":0,"forwardPE":0,"priceToBook":0,"returnOnEquity":0,"recommendationMean":0,"recommendationKey":"","targetMeanPrice":0,"numberOfAnalystOpinions":0,"analyst_earnings_data":"","dividendRate":0,"dividendYield":0,"payoutRatio":0,"totalEsg":0,"environmentScore":0,"socialScore":0,"governanceScore":0,"title":"","providerPublishTime":"","link":"","longBusinessSummary":"","longBusinessSummary_ja":"","quarterly_revenue":0,"quarterly_net_income":0,"quarterly_operating_profit":0,"enterprise_value":0,"price_fetched_at":"","company_officer_1_name":"","company_officer_1_title":"","company_officer_2_name":"","company_officer_2_title":"","company_officer_3_name":"","company_officer_3_title":"","company_officer_4_name":"","company_officer_4_title":"","company_officer_5_name":"","company_officer_5_title":"","company_officers_update_time":"","get_dividend_history_year1":0,"get_dividend_history_year2":0,"get_dividend_history_year3":0,"get_dividend_history_year4":0,"get_dividend_history_year5":0,"get_dividend_history_year6":0,"get_dividend_history_year7":0,"get_dividend_history_year8":0,"get_dividend_history_year9":0,"get_dividend_history_year10":0,"site-sidebar-layout":"default","site-content-layout":"","ast-site-content-layout":"","site-content-style":"default","site-sidebar-style":"default","ast-global-header-display":"","ast-banner-title-visibility":"","ast-main-header-display":"","ast-hfb-above-header-display":"","ast-hfb-below-header-display":"","ast-hfb-mobile-header-display":"","site-post-title":"","ast-breadcrumbs-content":"","ast-featured-img":"","footer-sml-layout":"","theme-transparent-header-meta":"","adv-header-id-meta":"","stick-header-meta":"","header-above-stick-meta":"","header-main-stick-meta":"","header-below-stick-meta":"","astra-migrate-meta-layouts":"default","ast-page-background-enabled":"default","ast-page-background-meta":{"desktop":{"background-color":"var(--ast-global-color-5)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"tablet":{"background-color":"","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"mobile":{"background-color":"","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""}},"ast-content-background-meta":{"desktop":{"background-color":"var(--ast-global-color-4)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"tablet":{"background-color":"var(--ast-global-color-4)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"mobile":{"background-color":"var(--ast-global-color-4)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""}},"jir_stock_code":"7419","jir_company_name":"Nojima Corporation","jir_importance":"\u2605\u2605\u2605\u2606\u2606","jir_publication_date":"2026-10-05","jir_source_link":"https:\/\/japanir.jp\/wp-content\/uploads\/2026\/10\/7419-20261005-01.pdf","jir_short_summary":"Announces amendments and finalization of the number of share acquisition rights granted to employees and subsidiary employees, exercise price, and related details. Post-amendment employee grants total 96,317 units, aggregate 113,597 units, with an exercise price of 122,800 yen per unit. Total value of shares for employee grants is 11,827,727,600 yen and for officer grants is 2,121,984,000 yen. Number of assignees revised to 1,487 employees and 3,275 subsidiary employees, totaling 4,841 people. Finalization date is set for 2026-10-05.","jir_summary":"### Summary of Amendments\nNojima Corporation resolved at the Board of Directors meeting to finalize and amend certain items related to stock options, including the number of assignees, number of share acquisition rights issued, and number of allotted shares. The total for employee grants is 96,317 units post-amendment, with an aggregate of 113,597 units, and the number of shares for employee grants is 9,631,700 shares. The exercise price has been determined at 122,800 yen per unit, and major terms such as the exercise period remain unchanged.\n\n### Future Schedule and Impact\nThe allotment date for the share acquisition rights is set as 2026-10-05, and the exercise period is from 2029-09-16 to 2031-09-15. The finalized details reflect changes in assignees due to resignations and other personnel movements. There are no changes to the officer grant portion, and the dilution impact on total issued shares and share count is expected to be limited.","jir_financial_highlights":"Number of share acquisition rights issued: Post-amendment 113,597 units (Pre-amendment 113,707 units \u2192 Post-amendment 113,597 units)\nType and number of shares underlying the share acquisition rights (employee grants): Post-amendment 9,631,700 shares (Pre-amendment 9,642,700 shares)\nAmount to be paid upon exercise of the share acquisition rights (exercise price): 122,800 yen\/unit (Finalized)","jir_category":"","jir_hashtags":"#Nojima, #StockOptionAmendment","jir_key_figures":"Number of share acquisition rights issued (post-amendment): 113,597 units\nTotal number of shares underlying the share acquisition rights (employee grants): 9,631,700 shares\nExercise price of the share acquisition rights: 122,800 yen\/unit","jir_meta_title":"Nojima Corporation \u2014 Partial Amendments and Finalization of Stock Option Grants | October 2026","jir_meta_description":"Nojima Corporation has finalized and amended the number of share acquisition rights, underlying share counts, and exercise price for employee and subsidiary employee stock options. Allotment date and exercise period remain as announced.","jir_og_title":"Nojima Corporation \u2014 Partial Amendments and Finalization of Stock Option Grants | October 2026","jir_og_description":"Nojima Corporation finalized and amended the number of stock option grants, underlying shares, and exercise price. The number of assignees has been updated to 4,841 people including employees and subsidiary employees.","jir_og_image_url":"\/assets\/og\/company-general_ir.jpg","jir_chart_data_collection":"[]","ir_related_company":8050,"ir_release_date":"","ir_type":"","ir_is_new":false,"ir_document_url":"","jir_ir_type":"stock_option","footnotes":""},"sector":[],"importance":[],"class_list":["post-127579","ir_release","type-ir_release","status-publish","hentry"],"yoast_head":"\n